Dr. Paurush Babbar of The Urology Group talks with Lincoln Ware of The Buzz 1230AM about Low-T therapies, breaking down myths and misconceptions.
Philip J. Buffington, MD, chief medical officer at The Urology Group, recently spoke at the Large Urology Group Practice Association’s (LUGPA) annual conference about Firmagon, a prostate cancer treatment drug.
The Urology Group seeks to help patients with advanced prostate cancer find drugs like Pluvicto that are in short supply. One patient received his medication from Italy due to limited quantities in the U.S. Being your own advocate is essential to making sure you can take advantage of every treatment option available.
A recent article in Romper Magazine revealed that although vasectomies are simpler, safer, and less expensive, tubal ligations (getting one’s “tubes tied”) outpace them 3 to 1 in the United States and are still performed far more often worldwide. In this article The Urology Group’s Dr. Paurush Babbar debunks common myths and fears men have about getting a…